Press Releases
ICU Medical, Inc. Announces Second Quarter 2020 Results
August 10, 2020
SAN CLEMENTE, Calif. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2020 .
ICU Medical Broadens its Non-PVC/Non-DEHP IV Solutions Portfolio by Entering Long-Term U.S. Distribution Agreement with Grifols for Certain Core IV Solution Products
August 10, 2020
SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI ) today announced that it has entered into
ICU Medical, Inc. Announces Time of Second Quarter 2020 Earnings Conference Call
July 15, 2020
SAN CLEMENTE, Calif. , July 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2020 earnings release
ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer’s Injection, USP Due to the Presence of Particulate Matter
May 8, 2020
Contact: Consumers ICU Medical, Inc. 1-844-654-7780 FOR IMMEDIATE RELEASE - May 08, 2020 LAKE FOREST, Illinois – ICU Medical, Inc. ) is voluntarily recalling one single lot of Lactated Ringer’s Injection, USP. The products are
ICU Medical, Inc. Announces First Quarter 2020 Results and Updates Fiscal Year 2020 Guidance
May 7, 2020
SAN CLEMENTE, Calif. , May 07, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2020 .
ICU Medical, Inc. Announces Time of First Quarter 2020 Earnings Conference Call
April 20, 2020
SAN CLEMENTE, Calif. , April 20, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2020 earnings release
ICU Medical, Inc. to Present at the Raymond James 41st Annual Institutional Investors Conference
February 28, 2020
SAN CLEMENTE, Calif. , Feb. 28, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond
ICU Medical, Inc. Announces Fourth Quarter 2019 Results
February 27, 2020
SAN CLEMENTE, Calif. , Feb. 27, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31,
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2019 Earnings Conference Call
February 6, 2020
SAN CLEMENTE, Calif. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2019
ICU Medical, Inc. to Present at the J.P. Morgan 38th Annual Healthcare Conference
January 7, 2020
SAN CLEMENTE, Calif. , Jan. 07, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P.